All In MedTech

Device Trial Radar · NCT06687590

Serranator POINT FORCE Registry

POst-Market ClINical Follow-up STudy oF the SerranatOR PTA Serration Balloon CathEter

Last checked: Nov 20, 2026Latest source record: May 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Jan 22, 2025

Primary completion

Jun 30, 2026

Study completion Aug 31, 2026

Sponsor

Lead sponsor
Cagent Vascular LLCNot on our public-company list
Sponsor type
Industry
Collaborators
Yale Cardiovascular Research Group; Julius Clinical
First posted
Nov 13, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this registry is to collect observational data under local standard of care and evaluate safety and performance of the Serranator® in treatment of peripheral artery disease (PAD), or dysfunctional native or synthetic arteriovenous dialysis fistulae in a real-world scenario. The data and conclusions derived from this study will be used to provide clinical evidence for the clinical evaluation process.

Conditions

  • Peripheral Artery Disease (PAD)
  • Dysfunctional AV Fistula
  • Dysfunctional AV Graft

Interventions

  • Peripheral balloon angioplastyDevice

    Serration balloon angioplasty of iliac, femoral, iliofemoral, popliteal, infrapopliteal and pedal arteries, or dysfunctional native or synthetic arteriovenous dialysis fistula

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Performance EndpointTime frame: Peri-procedural

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • HonorHealth

    Scottsdale, Arizona · Recruiting

  • Cedars-Sinai Medical Center

    Los Angeles, California · Recruiting

  • Hartford HealthCare

    Hartford, Connecticut · Recruiting

16 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.